Live Quote · NASDAQRNAHealthcare· Biotechnology

Atrium Therapeutics, Inc.

$6.92▼ 0.86%($-0.06)
MKT CAP $149.27MNEXT EARNINGS Feb 11, 2027
50%
Bullish
TickerSpark Score
49/100
▌ Weak
75
Valuation
35
Profitability
20
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RNA research report →

Analyst Price Target
$20.00+189.0% vs. today

Range $15 – $25

Analyst RatingBuy
8 Buy8 Hold0 Sell

Price Chart

-53.08% · this period
$16.54$11.48$6.43Feb 27Jul 14Nov 20
52-Week Range5% of range
Low
$6.36
Current
$6.92
High
$16.77